← Back to Search

Self-Management Survivorship Care for Lung and Colorectal Cancer

N/A

Recruiting

Led By Virginia Sun

Research Sponsored by City of Hope Medical Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

History of stage I-III disease

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 8 months

Awards & highlights

Study Summary

This trial tests a self-management program for cancer survivors to see if it improves follow-up care, communication with doctors, and quality of life.

Who is the study for?

This trial is for stage I-III non-small cell lung or colorectal cancer survivors who finished treatment at least 4 months ago. Participants must understand English and be willing to consent to the study's requirements. Those unable to comply with the study as judged by the investigator cannot join.Check my eligibility

What is being tested?

The trial examines a telehealth self-management program aimed at improving survivorship care for cancer survivors. It includes coaching on follow-up care, using tools like telemedicine, survivorship care plans, questionnaires, and quality-of-life assessments.See study design

What are the potential side effects?

Since this trial focuses on survivorship care rather than medication or invasive treatments, traditional side effects are not expected. However, participants may experience stress or discomfort related to discussing their cancer experience.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

My cancer was initially stage I, II, or III.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 8 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 8 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 8 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Care coordination

Oncologist/primary care providers (PCP) communication

PCP knowledge in survivorship care

+3 more

Other outcome measures

Outcome Measure for facilitators

Overall reach (participation rate) with primary care providers (Arm I)

Percentage of primary care providers who received a clinical care plan (Arm I)

+2 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Arm I (personalized care plan, telehealth sessions)Experimental Treatment4 Interventions

Patients receive a personalized care plan/resource manual. Patients also participate in 5 telehealth sessions with a nurse over 60 minutes each for 4 months (months 1-4) about self-management skills building, then 3 maintenance telehealth sessions with a nurse over 60 minutes each for 3 months (months 5-7) for additional self-management skills building support. A copy of patient's care plan is also sent to their PCP.

Group II: Arm II (ASCO care plan, telehealth sessions)Active Control3 Interventions

Patients receive an ASCO care plan. Patients also participate in 5 telehealth sessions with a nurse over 60 minutes each for 4 months (months 1-4) to answer questions on a handbook about life after cancer treatment, then 3 monthly telehealth sessions with a nurse over 60 minutes each for 3 months (months 5-7) to answer questions about the handbook. A copy of the ASCO care plan is also sent to their PCP.

0 / 1Eligibility criteria met

Find a Location

Who is running the clinical trial?

National Cancer Institute (NCI)NIH

13,660 Previous Clinical Trials

40,923,954 Total Patients Enrolled

City of Hope Medical CenterLead Sponsor

565 Previous Clinical Trials

1,921,046 Total Patients Enrolled

Virginia SunPrincipal InvestigatorCity of Hope Medical Center

10 Previous Clinical Trials

575 Total Patients Enrolled

Media Library

Self-Management Survivorship Care Clinical Trial Eligibility Overview. Trial Name: NCT04428905 — N/A

Lung Cancer Research Study Groups: Arm II (ASCO care plan, telehealth sessions), Arm I (personalized care plan, telehealth sessions)

Lung Cancer Clinical Trial 2023: Self-Management Survivorship Care Highlights & Side Effects. Trial Name: NCT04428905 — N/A

Self-Management Survivorship Care 2023 Treatment Timeline for Medical Study. Trial Name: NCT04428905 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is enrollment open at the present time for this research project?

"The details provided on clinicaltrials.gov show that the recruitment for this clinical trial is ongoing. It was first posted in July 2020 and recently updated in April 2022."

Answered by AI

How many people are currently participating in the trial?

"Affirmative. According to the official listing on clinicaltrials.gov, this research project is actively seeking participants; it was initially posted in July 2020 and last updated in April 2022. 414 people are required for participation at 1 single location."

Answered by AI

Recent research and studies

Journal of Cancer EducationJournal

Rationale and Design of a Telehealth Self-management, Shared Care Intervention for Post-treatment Survivors of Lung and Colorectal Cancer

Sun, Virginia, Anne Reb, Marc Debay, Marwan Fakih, and Betty Ferrell. 2021. “Rationale and Design of a Telehealth Self-management, Shared Care Intervention for Post-treatment Survivors of Lung and Colorectal Cancer”. Journal of Cancer Education. Springer Science and Business Media LLC. doi:10.1007/s13187-021-01958-8.

clinicaltrials.govStudy

Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer

2020. "Self-Management Survivorship Care in Stage I-III Non-small Cell Lung Cancer or Colorectal Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04428905.

All > Colorectal Cancer Los Angeles